title: Systemic treatment of hyperhidrosis.
abstract: Until quite recently, clinical guidelines and reviews on the treatment of hyperhidrosis advised against the use of systemic therapies based on their unacceptable adverse effects and a lack of evidence of usefulness. Numerous studies published over the past few years, however, have shown that, when used appropriately, these treatments are effective and in general have a favorable tolerability profile, making them an additional option for the treatment of hyperhidrosis, particularly for disease that is widespread, multifocal, or resistant to other treatments. In this review, the first of its kind, we examine the systemic therapies available for hyperhidrosis, including antihypertensives, psychoactive agents, and in particular oral anticholinergics, although none of these drugs are currently approved for this indication.
authors: Servicio de Dermatología, Hospital Costa del Sol, Marbella, Málaga, España. Electronic address: javierdelboz@yahoo.es.
authors: J
authors: J
authors: del Boz
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use; D018680:Cholinergic Antagonists / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D019468:Disease Management; D019317:Evidence-Based Medicine; D006024:Glycopyrrolate / Q000627:therapeutic use; D006801:Humans; D006945:Hyperhidrosis / Q000188:drug therapy*; D015201:Meta-Analysis as Topic; D056687:Off-Label Use; D011619:Psychotropic Drugs / Q000627:therapeutic use
chemical_list: D000959:Antihypertensive Agents; D018680:Cholinergic Antagonists; D011619:Psychotropic Drugs; D006024:Glycopyrrolate
keywords: Glicopirrolato; Glycopyrrolate; Hiperhidrosis; Hypehidrosis; Oxibutinina; Oxybutynin